Valuation : Extrawell Pharmaceutical Holdings Limited

Market Cap 232M 29.59M 25.5M 23.91M 21.82M 41.11M 2.83B 41.24M 284M 111M 1.43B 111M 109M 4.73B P/E 2025
0.61x
P/E 2026 -0.2x
Enterprise Value 208M 26.57M 22.9M 21.47M 19.6M 36.92M 2.54B 37.04M 255M 99.38M 1.28B 99.77M 97.6M 4.25B EV / Sales 2025
-13.5x
EV / Sales 2026 3.5x
Free-Float
65.45%
Yield 2025 *
-
Yield 2026 -
1 day+1.25%
1 week+3.85%
Current month+8.00%
1 month+8.00%
6 months+1.25%
Current year-1.22%
1 week 0.07
Extreme 0.073
0.08
1 month 0.07
Extreme 0.068
0.09
Current year 0.05
Extreme 0.054
0.12
1 year 0.05
Extreme 0.054
0.14
3 years 0.03
Extreme 0.026
0.15
5 years 0.03
Extreme 0.026
0.2
10 years 0.03
Extreme 0.026
0.46
Manager TitleAgeSince
Chief Executive Officer 45 2025-12-29
Director of Finance/CFO 54 -
Corporate Officer/Principal 63 2019-06-30
Director TitleAgeSince
Director/Board Member 68 2008-10-05
Director/Board Member 63 2008-09-30
Chairman 63 2014-11-12
Date Insider Type Main position Quantity % Market Cap.
7/9/25 Other

Director

139,700,000 5.8452%
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+3.85%-33.06%+62.00% 29.59M
-0.13%-6.44%+60.34%+114.35% 1,047B
+0.85%-0.81%+51.29%+63.71% 646B
-1.03%-3.58%+21.43%+72.25% 451B
-0.81%-3.91%+36.78%+36.73% 355B
-0.29%-2.52%+21.69%+38.35% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-1.05%-1.57%+50.30%+67.68% 234B
-1.11%-2.34%-19.95%-54.12% 203B
-2.14%-0.30%+28.95%+87.59% 181B
Average -0.49%-2.41%+21.93%+50.00% 365.93B
Weighted average by Cap. -0.39%-3.46%+37.89%+65.93%

Financials

2025 2026
Net sales 55.43M 7.07M 6.09M 5.71M 5.21M 9.82M 676M 9.85M 67.77M 26.44M 341M 26.54M 25.97M 1.13B 51.48M 6.57M 5.66M 5.31M 4.84M 9.12M 628M 9.15M 62.94M 24.56M 317M 24.65M 24.12M 1.05B
Net income 223M 28.4M 24.47M 22.94M 20.94M 39.46M 2.71B 39.58M 272M 106M 1.37B 107M 104M 4.54B -980M -125M -108M -101M -92.16M -174M -11.94B -174M -1.2B -467M -6.03B -469M -459M -19.99B
Net Debt -854M -109M -93.85M -88M -80.33M -151M -10.41B -152M -1.04B -407M -5.25B -409M -400M -17.42B -23.66M -3.02M -2.6M -2.44M -2.23M -4.19M -288M -4.21M -28.92M -11.28M -146M -11.33M -11.08M -483M
Logo Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Manufacturing segment is engaged in the development, manufacture and sales of pharmaceutical products. Its self-produced products include Transfer Factor Oral Solution, Wisk, ZhouBang and others. The Trading segment is engaged in the promotion and distribution of imported pharmaceuticals. Its imported products include Millibar and Skin Cap. The Gene Development segment is engaged in the commercial development and research, development of gene-related technologies.
Employees
158
Date Price Change Volume
26-08-31 HK$0.0810 +1.25% 730,000
26-08-28 HK$0.0800 +2.56% 630,000
26-08-27 HK$0.0780 -2.50% 910,000
26-08-26 HK$0.0800 +1.27% 290,000
26-08-25 HK$0.0790 +1.28% 940,000

Annual profits - Rate of surprise